PLAUR and neoplasm: uPAR-targeted nanoplatforms carrying therapeutic agents have great potential in enhancing active tumour targeting, improving delivery efficiency, reducing drug toxicity, increasing the hydrophilicity of hydrophobic drugs, achieving tumour diagnosis and treatment integration, and in multimodal synergistic antitumor applications.